• Provider Compendium
    Oct. 07, 2026

    Pre-payment integrity is gaining momentum as health plans look to shift left with payment accuracy activities, moving from retrospective recovery toward earlier intervention before claims are paid. Rising medical costs, provider abrasion from post-pay recoveries, and…
  • Technology Awareness Deep Dive
    June 29, 2026

    This report examines the evolution of data center cooling as it becomes a foundational enabler of AI-scale infrastructure by supporting the rapid growth of graphics processing unit-intensive workloads, High-performance Computing (HPC) workloads, and machine learning workloads. The…
  • Viewpoint
    Feb. 23, 2023

    Labeling and artwork are vital components of the life sciences industry, as they ensure regulatory compliance and can be used in packaging, online, and in the supply chain. Failure to comply with Good Manufacturing Practice (GMP)…
  • Viewpoint
    Sep. 30, 2022

    The rising burden of chronic diseases worldwide is driving life sciences companies’ drug development efforts. These drug development efforts need to abide by the strict drug safety regulations of public health organizations, such as the US…
  • Provider Compendium
    April 30, 2021

    The Pharmacovigilance - Complaint Management Operations - Service Provider Compendium – provides accurate, comprehensive, and fact-based snapshots of 22 pharmacovigilance and complaint management service providers. It presents providers’ scale of operations, technology solutions, and delivery locations,…
  • Thematic Report
    April 24, 2019

    In 2018, the Life Sciences (LS) industry continued to struggle with achieving growth and accelerating time-to-market amid the challenges of rising costs, pricing regulations, and policy changes. Digital transformation had been identified by many enterprises as…
  • Thematic Report
    Nov. 03, 2017

    The life sciences BPO service provider profile compendium provides accurate, comprehensive, and fact-based profile snapshots of 13 service providers in the market. Specifically, the report allows for comparison of the service providers on their areas of…
  • Webinar Deck
    Sep. 13, 2017

    On August 25, a webinar, focused on Innovation in Pharmacovigilance (PV), featured expert speakers from Everest Group. The webinar illustrated how spend on PV by pharma firms has increased considerably during the last decade; however, drug…
  • Viewpoint
    June 02, 2017

    Despite spending billions of dollars, lack of drug-related Adverse Event (AE) reporting and subsequent drug safety breaches continue to impact millions of lives and cause financial losses. Pouring more money at their Pharmacovigilance (PV) arms is…